Document is current
Any future updates will be listed below
-
Authors
Clarke, Connor
Kouroupa, Athanasia
Royston, Rachel
Hassiotis, Angela
Jin, Yufei
Cooper, Vivien
Daniels, Robert
Grimley, Lisa
Hay, Sue
Marston, Louise
Odeyemi, Olawole
Penfold, Ian
Pullar, Claire
Rapaport, Penny
Sanger, Kate
Southworth, Adam
Taggart, Laurence
Ali, Afia
-
Funding
Funding for this research was provided by:
National Institute for Health and Care Research (NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120, NIHR200120)
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 16 January 2025
First Online: 6 March 2025
Declarations
:
: The PETAL trial received ethical approval from the Wales 7 REC committee on 31/10/2022 (REC reference: 22/WA/0267). The trial is ISRCTN registered (ISRCTN71781827), but ethical approval was not required for the PETAL PPI impact study specifically. The contributors provided verbal consent to take part in the interviews and focus groups.
: Not applicable.
: The authors declare no competing interests.
